
Alfasigma is a privately held global healthcare company founded over 75 years ago in Italy, where it remains headquartered today in Bologna and Milan. The Group operates in over 100 markets spanning Europe, North and South America, Asia, and Africa.
Over three years ago, we embarked on a transformative journey to become a truly global innovative healthcare company with a leading focus on Gastrointestinal (GI) health. We have experienced remarkable growth, nearly doubled our revenues, expanding geographically, and integrating several key acquisitions. We have also evolved our portfolio, expanded into rare and specialty segments, and strengthened our pipeline and people's capabilities.
But our journey is far from complete! In fact, this is just the beginning of a bold new chapter in Alfasigma's history. We are committed to advancing innovation and leveraging our deep expertise to provide better health and a better quality of life for patients and consumers worldwide and expand our reach across diverse markets.
The Global Franchise Head Gastroenterology & Rare Disease is responsible for defining and executing the global Gastroenterology & Rare Disease Therapeutic Area Strategy to maximize long-term franchise value and patient impact. This role leads the development of global brand strategies, ensures excellence in brand planning and execution, drives resource allocation decisions, and partners closely with Research & Development, Medical Affairs, and key commercial functions to build a sustainable and differentiated Gastroenterology & Rare Disease franchise.
The role has full accountability for delivering the franchise growth ambition through effective portfolio prioritization, strategic investment decisions, and leadership of the Global Gastroenterology & Rare Disease Marketing Team.
You will be part of a truly global team with high exposure to Alfasigma's Leadership Team, where your impact will be substantial and highly valued. Your personal development will be taken seriously, and your growth will go hand in hand with the growth of the company. We believe that innovation can be translated in many ways, including your own professional development.
At Alfasigma, we foster a culture where the courage to innovate is key to our success.
Our commitment to people and patients is at the heart of everything we do. We value diversity and welcome individuals with unique perspectives and experiences. We believe that open-mindedness, collaboration, and a shared passion for innovation are essential to achieving meaningful progress.
Join Alfasigma and become part of a forward-thinking team dedicated to shaping the future of healthcare and improving outcomes for patients living with gastrointestinal and rare diseases.
Location: Basel, Switzerland.
This is a Basel-based global role requiring frequent travel to Milan, Italy, where Alfasigma's Global Headquarters are located, as well as occasional international travel when needed.
At Alfasigma, we foster a culture where the courage to innovate is key to our success.
We offer a competitive salary, comprehensive benefits, and extensive opportunities for professional growth and development.
Our commitment to people and patients is at the heart of everything we do. We value diversity and welcome individuals with unique perspectives and experiences. We believe that open-mindedness, collaboration, and a shared passion for innovation are essential to achieving meaningful progress.
Join Alfasigma and become part of a forward-thinking team dedicated to shaping the future of the pharmaceutical industry.

Alfasigma is a global pharmaceutical company founded over 75 years ago in Italy, where it is headquartered (in Bologna and Milan).
The Group operates in over 100 markets spanning Europe, North and South America, Asia, and Africa. It has offices in many countries, including Italy, the US, Spain, Germany, Mexico, and China; production sites in Italy (Pomezia, RM; Alanno, PE; Sermoneta, LT; Trezzano Rosa, MI), Spain (Tortosa, Baix Ebre), and the United States (Shreveport, Louisiana); and R&D labs in Italy (Pomezia and Bergamo).
Alfasigma employs approximately 4,000 people dedicated to research, development, production, and distribution of medicinal products, contributing to its mission to provide better health and a better quality of life for patients, caregivers, and healthcare providers.
It focuses on three main therapeutic areas: Gastroenterology, Vascular, and Rheumatology. Its portfolio spans from primary care to specialty care, rare disease medications, and consumer health products, including medical foods and nutraceuticals.
Read here our social media netiquette: https://it.alfasigma.com/informative-privacy/netiquettesocialnetwork/